Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Yavneh, ISR
42 Hayarkon st.
Northern Industrial Zone
Yavneh, 81227, ISR

People

Funding

Tags

Avraham Pharmaceuticals

Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer’s disease, supporting the development of its lead product candidate, ladostigil.

Recent Milestones

Videos

Screenshots

Sources

  1. Avraham Pharmaceuticals, Ltd.: Series A $9M (onbiovc.com) [edit]
  2. Avraham Pharmaceuticals Closes $3M Financing (finsmes.com) [edit]
  3. Avraham Pharmaceuticals Raises $ 5.7M in Funding (finsmes.com) [edit]
Edit This Page
Last Edited 2/21/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy